WealthPLAN Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-40
Closed -$17.8K 533
2023
Q2
$17.8K Hold
40
﹤0.01% 703
2023
Q1
$18.4K Buy
+40
New +$19K ﹤0.01% 746

Other funds holding ELV

WealthPLAN Partners's ELV Position: Q3 2023 in Review

WealthPLAN Partners sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 40 shares — an estimated $17.8K sold.

WealthPLAN Partners first reported a position in ELV in Q1 2023 and held it in 2 quarters. The position peaked at $18.4K in Q1 2023. 1,525 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • WealthPLAN Partners reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
  • WealthPLAN Partners sold 40 Elevance Health shares in Q3 2023, an estimated $17.8K.
  • WealthPLAN Partners first reported a position in Elevance Health in Q1 2023 and held it in 2 quarters.
  • WealthPLAN Partners's Elevance Health position peaked at $18.4K in Q1 2023.
  • 1,525 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on WealthPLAN Partners's 13F filing for Q3 2023, filed 2 Nov 2023.